Common variants of TLR1 associate with organ dysfunction and sustained pro-inflammatory responses during sepsis

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Pino Yanes, Maria ^a,b   Corrales, Almudena ^a,b   Casula, Milena ^a,c   Blanco, Jesús ^a,d   Muriel, Arturo ^a,d   Espinosa, Elena ^b   García Bello, Miguel ^c   Torres, Antoni ^a,e,f   Ferrer, Miguel ^a,e,f   Zavala, Elizabeth ^a,e   Villar, Jesús ^a,c,g   Flores, Carlos ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO NUESTRA SEÑORA DE CANDELARIA   (Spain)

^c HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^d HOSPITAL UNIVERSITARIO RÍO HORTEGA   (Spain)

^e HOSPITAL CLÍNIC   (Spain)

^f UNIVERSITY OF BARCELONA   (Spain)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; TOLL LIKE RECEPTOR 1; CYTOKINE;

ACUTE LUNG INJURY; ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; EUROPEAN AMERICAN; FEMALE; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTENSIVE CARE UNIT; ISCHEMIA; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEPSIS; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; BLOOD; COHORT ANALYSIS; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; C-REACTIVE PROTEIN; COHORT STUDIES; CYTOKINES; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEPSIS; TOLL-LIKE RECEPTOR 1;

EID: 78149419608     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013759     Document Type: Article

References (39)

1. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandia F, et al. (2008) Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care 12: R158.
2. Matthay MA, Zimmerman GA (2005) Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 33: 319-327.
3. Wurfel MM, Park WY, Radella F, Ruzinski J, Sandstrom A, et al. (2005) Identification of high and low responders to lipopolysaccharide in normal subjects: an unbiased approach to identify modulators of innate immunity. J Immunol 175: 2570-2578.
4. de Craen AJ, Posthuma D, Remarque EJ, van den Biggelaar AH, Westendorp RG, et al. (2005) Heritability estimates of innate immunity: an extended twin study. Genes Immun 6: 167-170.
5. Aziz RK, Kansal R, Abdeltawab NF, Rowe SL, Su Y, et al. (2007) Susceptibility to severe Streptococcal sepsis: use of a large set of isogenic mouse lines to study genetic and environmental factors. Genes Immun 8: 404-415.
6. Trinchieri G, Sher A (2007) Cooperation of Toll-like receptor signals in innate immune defence. Nat Rev Immunol 7: 179-190.
7. Roger T, Froidevaux C, Le Roy D, Reymond MK, Chanson AL, et al. (2009) Protection from lethal gram-negative bacterial sepsis by targeting Toll-like receptor 4. Proc Natl Acad Sci U S A 106: 2348-2352.
8. Alves-Filho JC, Freitas A, Souto FO, Spiller F, Paula-Neto H, et al. (2009) Regulation of chemokine receptor by Toll-like receptor 2 is critical to neutrophil migration and resistance to polymicrobial sepsis. Proc Natl Acad Sci USA 106: 4018-4023.
9. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, et al. (2000) TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 25: 187-191.
10. Khor CC, Chapman SJ, Vannberg FO, Dunne A, Murphy C, et al. (2007) A Mal functional variant is associated with protection against invasive pneumo-coccal disease, bacteremia, malaria and tuberculosis. Nat Genet 39: 523-528.
11. Shey MS, Randhawa AK, Bowmaker M, Smith E, Scriba TJ, et al. Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced interleukin-6 secretion. Genes Immun. In press.
12. Arcaroli J, Silva E, Maloney JP, He Q, Svetkauskaite D, et al. (2006) Variant IRAK-1 haplotype is associated with increased nuclear factor-kappaB activation and worse outcomes in sepsis. Am J Respir Crit Care Med 173: 1335-1341.
13. Flores C, Perez-Mendez L, Maca-Meyer N, Muriel A, Espinosa E, et al. (2009) A common haplotype of the LBP gene predisposes to severe sepsis. Crit Care Med 37: 2759-2766.
14. Wurfel MM, Gordon AC, Holden TD, Radella F, Strout J, et al. (2008) Toll-like receptor 1 polymorphisms affect innate immune responses and outcomes in sepsis. Am J Respir Crit Care Med 178: 710-720.
15. Clark MF, Baudouin SV (2006) A systematic review of the quality of genetic association studies in human sepsis. Intensive Care Med 32: 1706-1712.
16. Flores C, Pino-Yanes MM, Villar J (2008) A quality assessment of genetic association studies supporting susceptibility and outcome in acute lung injury. Crit Care 12: R130.
17. Hawn TR, Misch EA, Dunstan SJ, Thwaites GE, Lan NT, et al. (2007) A common human TLR1 polymorphism regulates the innate immune response to lipopeptides. Eur J Immunol 37: 2280-2289.
18. Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, et al. (2009) Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5: e1000562.
19. Villar J, Perez-Mendez L, Flores C, Maca-Meyer N, Espinosa E, et al. (2007) A CXCL2 polymorphism is associated with better outcomes in patients with severe sepsis. Crit Care Med 35: 2292-2297.
20. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, et al. (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256.
21. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824.
22. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, et al. (1998) Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on ''sepsis-related problems'' of the European Society of Intensive Care Medicine. Crit Care Med 26: 1793-1800.
23. Cabrera de Leon A, Rodriguez Perez Mdel C, Almeida Gonzalez D, Dominguez Coello S, Aguirre Jaime A, et al. (2008) [Presentation of the ''CDC de Canarias'' cohort: objectives, design and preliminary results]. Rev Esp Salud Publica 82: 519-534.
24. Ahmadi KR, Weale ME, Xue ZY, Soranzo N, Yarnall DP, et al. (2005) A single-nucleotide polymorphism tagging set for human drug metabolism and transport. Nat Genet 37: 84-89.
25. Villar J, Perez-Mendez L, Espinosa E, Flores C, Blanco J, et al. (2009) Serum lipopolysaccharide binding protein levels predict severity of lung injury and mortality in patients with severe sepsis. PLoS One 4: e6818.
26. Wigginton JE, Cutler DJ, Abecasis GR (2005) A note on exact tests of Hardy-Weinberg equilibrium. Am J Hum Genet 76: 887-893.
27. Gonzalez JR, Armengol L, Sole X, Guino E, Mercader JM, et al. (2007) SNPassoc: an R package to perform whole genome association studies. Bioinformatics 23: 644-645.
28. Wang K (2009) Testing for genetic association in the presence of population stratification in genome-wide association studies. Genet Epidemiol 33: 637-645.
29. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL (2004) A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet 68: 165-177.
30. Storey JD, Tibshirani R (2003) Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440-9445.
31. Barrett JC, Fry B, Maller J, Daly MJ (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
32. Johnson CM, Lyle EA, Omueti KO, Stepensky VA, Yegin O, et al. (2007) Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of TLR1 but protects against leprosy. J Immunol 178: 7520-7524.
33. Misch EA, Macdonald M, Ranjit C, Sapkota BR, Wells RD, et al. (2008) Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction. PLoS Negl Trop Dis 2: e231.
34. Baudouin SV, Saunders D, Tiangyou W, Elson JL, Poynter J, et al. (2005) Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 366: 2118-2121.
35. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, et al. (2006) Sepsis in European intensive care units: results of the SOAP study. Crit Care Med 34: 344-353.
36. Ma X, Liu Y, Gowen BB, Graviss EA, Clark AG, et al. (2007) Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS One 2: e1318.
37. Schuring RP, Hamann L, Faber WR, Pahan D, Richardus JH, et al. (2009) Polymorphism N248S in the human Toll-like receptor 1 gene is related to leprosy and leprosy reactions. J Infect Dis 199: 1816-1819.
38. Hamann L, Bedu-Addo G, Eggelte TA, Schumann RR, Mockenhaupt FP (2010) The toll-like receptor 1 variant S248N influences placental malaria. Infect Genet Evol 10: 785-789.
39. Georgel P, Macquin C, Bahram S (2009) The heterogeneous allelic repertoire of human toll-like receptor (TLR) genes. PLoS One 4: e7803.